UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 422

Sortiert nach

DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines

PloS one, 2010-02, Vol.5 (2), p.e9359-e9359

2010

Volltextzugriff (PDF)

Secondary mutations as a mechanism of cisplatin resistance in BRCA2 -mutated cancers

Nature, 2008-02, Vol.451 (7182), p.1116-1120

2008

Volltextzugriff (PDF)

Circulating microRNAs as stable blood-based markers for cancer detection

Proceedings of the National Academy of Sciences - PNAS, 2008-07, Vol.105 (30), p.10513-10518

2008

Volltextzugriff (PDF)

Direct Activation of TRPC3 Channels by the Antimalarial Agent Artemisinin

Cells (Basel, Switzerland), 2020-01, Vol.9 (1), p.202

2020

Volltextzugriff (PDF)

Estradiol analogs attenuate autophagy, cell migration and invasion by direct and selective inhibition of TRPML1, independent of estrogen receptors

Scientific reports, 2021-04, Vol.11 (1), p.8313-14, Article 8313

2021

Volltextzugriff (PDF)

Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors

Gynecologic oncology, 2016-01, Vol.140 (1), p.138-144

2016

Volltextzugriff (PDF)

Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus

American Journal of Physiology: Cell Physiology, 2005-04, Vol.288 (4), p.C769-C783

2005

Volltextzugriff (PDF)

Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity

PloS one, 2011-01, Vol.6 (1), p.e16186-e16186

2011

Volltextzugriff (PDF)

Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal mass

Scientific reports, 2021-09, Vol.11 (1), p.18156-18156, Article 18156

2021

Volltextzugriff (PDF)

Pharmacological inhibition of focal segmental glomerulosclerosis‐related, gain of function mutants of TRPC6 channels by semi‐synthetic derivatives of larixol

British journal of pharmacology, 2017-11, Vol.174 (22), p.4099-4122

2017

Volltextzugriff (PDF)

TDP-43 self-interaction is modulated by redox-active compounds Auranofin, Chelerythrine and Riluzole

Scientific reports, 2018-02, Vol.8 (1), p.2248-14, Article 2248

2018

Volltextzugriff (PDF)

Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries

PloS one, 2009-04, Vol.4 (4), p.e5311-e5311

2009

Volltextzugriff (PDF)

An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription

Nucleic acids research, 2012-01, Vol.40 (2), p.499

2012

Volltextzugriff (PDF)

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens

Cancer prevention research (Philadelphia, Pa.), 2011-03, Vol.4 (3), p.365-374

2011

Volltextzugriff (PDF)

Longitudinal Screening Algorithm That Incorporates Change Over Time in CA125 Levels Identifies Ovarian Cancer Earlier Than a Single-Threshold Rule

Journal of clinical oncology, 2013-01, Vol.31 (3), p.387-392

2013

Volltextzugriff (PDF)

Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition

Gynecologic oncology, 2010-01, Vol.116 (1), p.117-125

2010

Volltextzugriff (PDF)

Validation of LRG1 as a potential biomarker for detection of epithelial ovarian cancer by a blinded study

PloS one, 2015-03, Vol.10 (3), p.e0121112

2015

Volltextzugriff (PDF)

The ethoxycarbonyl group as both activating and protective group in N -acyl-Pictet-Spengler reactions using methoxystyrenes. A short approach to racemic 1-benzyltetrahydroisoquinoline alkaloids

Beilstein journal of organic chemistry, 2021-11, Vol.17 (1), p.2716-2725

2021

Volltextzugriff (PDF)

Proteins Associated with Cisplatin Resistance in Ovarian Cancer Cells Identified by Quantitative Proteomic Technology and Integrated with mRNA Expression Levels

Molecular & cellular proteomics, 2006-03, Vol.5 (3), p.433-443

2006

Volltextzugriff (PDF)

Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers

Proceedings of the National Academy of Sciences - PNAS, 2013-04, Vol.110 (15), p.6109-6114

2013

Volltextzugriff (PDF)

A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer

Cancer prevention research (Philadelphia, Pa.), 2011-03, Vol.4 (3), p.375-383

2011

Volltextzugriff (PDF)

Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer

PloS one, 2015-11, Vol.10 (11), p.e0142911

2015

Volltextzugriff (PDF)

Bead-Based ELISA for Validation of Ovarian Cancer Early Detection Markers

Clinical cancer research, 2006-04, Vol.12 (7), p.2117-2124

2006

Volltextzugriff (PDF)

1 – 25 von 422

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(371)
Mit Volltextzugriff
(379)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(281)
Life Sciences & Biomedicine
(237)
Humans
(231)
Female
(162)
Middle Aged
(104)
Aged
(95)
Biological And Medical Sciences
(79)
Medical Sciences
(73)
Oncology
(73)
Adult
(60)
Tumors
(55)
Animals
(47)
Ovarian Cancer
(47)
Public, Environmental & Occupational Health
(45)
Aged, 80 And Over
(43)
Male
(40)
Breast Cancer
(36)
Cancer
(34)
Gynecology. Andrology. Obstetrics
(31)
Ovarian Neoplasms - Diagnosis
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines

A mouse to human search for plasma proteome changes associated with pancreatic tumor development

Secondary mutations as a mechanism of cisplatin resistance in BRCA2 -mutated cancers

Circulating microRNAs as stable blood-based markers for cancer detection

Agonist-mediated switching of ion selectivity in TPC2 differentially promotes lysosomal function

Direct Activation of TRPC3 Channels by the Antimalarial Agent Artemisinin

Estradiol analogs attenuate autophagy, cell migration and invasion by direct and selective inhibition of TRPML1, independent of estrogen receptors

Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors

Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus

Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity

Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal mass

Pharmacological inhibition of focal segmental glomerulosclerosis‐related, gain of function mutants of TRPC6 channels by semi‐synthetic derivatives of larixol

TDP-43 self-interaction is modulated by redox-active compounds Auranofin, Chelerythrine and Riluzole

Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries

An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens

Longitudinal Screening Algorithm That Incorporates Change Over Time in CA125 Levels Identifies Ovarian Cancer Earlier Than a Single-Threshold Rule

Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition

Validation of LRG1 as a potential biomarker for detection of epithelial ovarian cancer by a blinded study

The ethoxycarbonyl group as both activating and protective group in N -acyl-Pictet-Spengler reactions using methoxystyrenes. A short approach to racemic 1-benzyltetrahydroisoquinoline alkaloids

Proteins Associated with Cisplatin Resistance in Ovarian Cancer Cells Identified by Quantitative Proteomic Technology and Integrated with mRNA Expression Levels

Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers

A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer

Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer

Bead-Based ELISA for Validation of Ovarian Cancer Early Detection Markers

Suchergebnisse filtern